微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.13% | 11.52% | -76.46% | 34/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 9.05% | -31.34% | 29.66% | 19/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 6.98% | -20.05% | 53.07% | 24/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.56% | -7.69% | 138.74% | 27/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 1.91% | -2.55% | -85.51% | 38/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 13.18% | 3.37% | 50.97% | 15/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 8.73% | 2.95% | 76.72% | 23/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 4.94% | 4.66% | 152.04% | 30/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.96% | 6.52% | -84.63% | 45/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.75% | 11.35% | 50.35% | 16/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 8.48% | -0.47% | 79.66% | 25/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.72% | 26.2% | 156.52% | 27/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.84% | 10.84% | -83.93% | 39/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 11.45% | -1.38% | 34.39% | 21/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 8.52% | 12.7% | 127.81% | 29/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.74% | 23.84% | 125.3% | 41/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.66% | -3.49% | -85.7% | 45/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 11.61% | -5.3% | 53.57% | 15/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 7.56% | -3.32% | 150.33% | 31/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 3.02% | -25.8% | 75.58% | 40/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.72% | -21.46% | -85.97% | 38/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 12.26% | 13.41% | 56.78% | 20/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 7.82% | 9.99% | 92.14% | 30/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 4.07% | 39.38% | 85.84% | 39/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.19% | 22.35% | -79.74% | 41/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 10.81% | 13.08% | 52.04% | 29/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 7.11% | 29.98% | 143.49% | 38/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 2.92% | 32.13% | 63.13% | 46/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 1.79% | 13.29% | -81.28% | 42/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 9.56% | 20.25% | 74.77% | 35/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 5.47% | 50.69% | 147.51% | 47/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 2.21% | 7.8% | 39.87% | 55/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.58% | 41.07% | -80.13% | 43/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 7.95% | 33.17% | 119.01% | 44/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 3.63% | 1.11% | 77.07% | 47/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 2.05% | -20.85% | 83.04% | 53/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 1.12% | -20% | -81.24% | 44/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 5.97% | -26.75% | 66.3% | 50/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 3.59% | -28.91% | 38.61% | 46/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 2.59% | -19.31% | 85% | 46/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 1.4% | -13.58% | -82.82% | 42/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |